Home Training Clinical Practice Alert: Cervical Cancer Screening and Emergency Contraception

Clinical Practice Alert: Cervical Cancer Screening and Emergency Contraception

March 24, 2020

This webinar features two new Family PACT Clinical Practice Alerts.

Cervical Cancer Screening

Topics in this portion of the webinar will include benefits through Family PACT that have been expanded to include high-risk HPV-alone screening, use of this test, alternative cervical cancer screening options, and new guidelines regarding cervical cancer screening for females who are HIV positive or who are immunocompromised.

Emergency Contraception

Topics in this portion of the webinar will include the relationship between body weight and emergency contraception failure rates, when oral contraceptives can be started with females who have used ulipristal acetate, options for accessing emergency contraceptive pills and the use of the copper IUD as emergency contraception.

Presenters:

Resources:

Extragenital Screening

Home Resources Extragenital Screening

Extragenital Screening

Don’t forget to swab! Among men who have sex with men, 84% of gonorrhea and chlamydia infections would be missed with urine-only screening1. Make sure your clients are screened for gonorrhea and chlamydia of the throat and rectum.

What:	Extragenital Screening for Gonorrhea and Chlamydia
Where:	Rectum and throat
Who:	Men who have sex with men (MSM), transgender women, people living with HIV, and people on PrEP who report having receptive anal and/or oral sex
When:	At least annually, or every 3 to 6 months as needed based on exposure
Why:	When urine-only screening is performed, up to 90% of rectal gonorrhea and 77% of rectal chlamydia infections remain untreated¹. HIV-negative men diagnosed with rectal infections are excellent candidates for PrEP, because they have a high risk of HIV infection
How:	Swab specimen (self or clinician-collected swab)

The California Prevention Training Center supports clinics and providers in implementing rectal and pharyngeal STI screening.

For more information, contact us.

Resources for Providers

FDA clears first diagnostic tests for extragenital testing for chlamydia and gonorrhea, FDA New Release
May 23, 2019

Extragenital Chlamydia and Gonorrhea Among Community Venue–Attending MSM, CDC MMWR
April 11, 2019

CA Department of Public Health, Dear Colleague Letter
February 20, 2019

HIV incidence among men with and those without sexually transmitted rectal infections, Clinical Infectious Diseases
October 15, 2013

National Coalition of STD Directors – Extragenital Testing

NYC Department of Health and Mental Hygiene – STI’s Among MSM Protocol Card

Resources for Clinics

Self Swab Instructional Posters:

Rectal, Throat, and Vaginal Self-Swab

Rectal Self-Swab

Throat Self-Swab

Vaginal Self-Swab

CDC Recommendations for Laboratory-Based Detection of Gonorrhea and Chlamydia, March 14, 2014

Verification of Patient Self-Collected Extragenital Nucleic Acid Amplification Tests

Resources for Patients

CDC Just Diagnosed – Gonorrhea and Chlamydia

CDC PrEP Resources

Please PrEP Me – Provider Locator

Building Healthy Online Communities – Sexual Health Information

Marcus JL, Bernstein KT, Kohn RP, Liska S, Philip SS. Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men. Sexually transmitted diseases. 2011 Oct 1;38(10):922-4.

Home Training The Evolving Well Woman Visit

The Evolving Well Woman Visit

April 26, 2018

The contents of the well-woman visit have changed significantly in the past decade, such that many screening tests are performed in modified age groups and at different screening intervals. This webinar will review the well-woman health screening recommendations published by the California Department of Public Health (CDPH), U.S. Preventive Services Task Force (USPSTF), American College of Obstetrics and Gynecology (ACOG) and other national organizations.

The following topics are covered in detail:

Reproductive goals counseling
Use of newer cervical cancer screening technologies
Utility of screening clinical breast exams and screening pelvic exams
Coding for well-woman visits

Presenter:

Michael Policar, MD, MPH

Resources:

Webinar Q & A